Tag: Varian

Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia

Cardiac RADIoablation versus repeat catheter Ablation: a pivotal randomized clinical Trial Evaluating safety and efficacy for patients with high-risk refractory Ventricular Tachycardia (RADIATE-VT) PALO ALTO, Calif., May 19, 2023 /PRNewswire/ — Varian, a Siemens Healthineers company, announced today that the first participant has been treated in the RADIATE-VT™ […]

Varian Receives Investigational Device Exemption for Cardiac Radioablation Clinical Trial, RADIATE-VT

Trial Represents an Opportunity to Evaluate a Non-Invasive Treatment Option for Patients with High-Risk Refractory Ventricular Tachycardia PALO ALTO, Calif., Jan. 19, 2023 /PRNewswire/ — Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) approved an Investigational […]

Varian Receives FDA “Breakthrough Device Designation” for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)

– Varian’s CRA system has been designated a “breakthrough device” by the FDA because of its potential to offer a more effective treatment for select patients with refractory VT. – Technology being developed will be assessed in clinical studies as […]

Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable Microcatheters

Patented technology provides interventionalists with 3D-controlled bending and navigation capabilities for peripheral vascular, neurovascular and cardiology indications PALO ALTO, Calif. and PETACH TIKVA, Israel, March 25, 2021 /PRNewswire/ — Varian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd., a medical device […]